224 related articles for article (PubMed ID: 17341585)
1. Impaired secretion of apolipoprotein E2 from macrophages.
Fan D; Qiu S; Overton CD; Yancey PG; Swift LL; Jerome WG; Linton MF; Fazio S
J Biol Chem; 2007 May; 282(18):13746-53. PubMed ID: 17341585
[TBL] [Abstract][Full Text] [Related]
2. Human LDL receptor enhances sequestration of ApoE4 and VLDL remnants on the surface of hepatocytes but not their internalization in mice.
Altenburg M; Arbones-Mainar J; Johnson L; Wilder J; Maeda N
Arterioscler Thromb Vasc Biol; 2008 Jun; 28(6):1104-10. PubMed ID: 18369154
[TBL] [Abstract][Full Text] [Related]
3. Apolipoprotein E-low density lipoprotein receptor interaction affects spatial memory retention and brain ApoE levels in an isoform-dependent manner.
Johnson LA; Olsen RH; Merkens LS; DeBarber A; Steiner RD; Sullivan PM; Maeda N; Raber J
Neurobiol Dis; 2014 Apr; 64():150-62. PubMed ID: 24412220
[TBL] [Abstract][Full Text] [Related]
4. Differential Signaling Mediated by ApoE2, ApoE3, and ApoE4 in Human Neurons Parallels Alzheimer's Disease Risk.
Huang YA; Zhou B; Nabet AM; Wernig M; Südhof TC
J Neurosci; 2019 Sep; 39(37):7408-7427. PubMed ID: 31331998
[TBL] [Abstract][Full Text] [Related]
5. Apolipoprotein E isoforms and their Cys-thiol modifications impact LRP1-mediated metabolism of triglyceride-rich lipoproteins.
Matsuura H; Akahane S; Kaido T; Kamijo T; Sakamoto K; Yamauchi K
FEBS Lett; 2024 Feb; 598(3):347-362. PubMed ID: 38279679
[TBL] [Abstract][Full Text] [Related]
6. Hyperlipidemia of ApoE2(Arg(158)-Cys) and ApoE3-Leiden transgenic mice is modulated predominantly by LDL receptor expression.
van Dijk KW; van Vlijmen BJ; de Winther MP; van 't Hof B; van der Zee A; van der Boom H; Havekes LM; Hofker MH
Arterioscler Thromb Vasc Biol; 1999 Dec; 19(12):2945-51. PubMed ID: 10591674
[TBL] [Abstract][Full Text] [Related]
7. Opposing effects of viral mediated brain expression of apolipoprotein E2 (apoE2) and apoE4 on apoE lipidation and Aβ metabolism in apoE4-targeted replacement mice.
Hu J; Liu CC; Chen XF; Zhang YW; Xu H; Bu G
Mol Neurodegener; 2015 Mar; 10():6. PubMed ID: 25871773
[TBL] [Abstract][Full Text] [Related]
8. Interaction of nascent ApoE2, ApoE3, and ApoE4 isoforms expressed in mammalian cells with amyloid peptide beta (1-40). Relevance to Alzheimer's disease.
Aleshkov S; Abraham CR; Zannis VI
Biochemistry; 1997 Aug; 36(34):10571-80. PubMed ID: 9265639
[TBL] [Abstract][Full Text] [Related]
9. Effect of macrophage-derived mouse ApoE, human ApoE3-Leiden, and human ApoE2 (Arg158-->Cys) on cholesterol levels and atherosclerosis in ApoE-deficient mice.
Van Eck M; Herijgers N; Van Dijk KW; Havekes LM; Hofker MH; Groot PH; Van Berkel TJ
Arterioscler Thromb Vasc Biol; 2000 Jan; 20(1):119-27. PubMed ID: 10634808
[TBL] [Abstract][Full Text] [Related]
10. Apolipoprotein E: from cardiovascular disease to neurodegenerative disorders.
Mahley RW
J Mol Med (Berl); 2016 Jul; 94(7):739-46. PubMed ID: 27277824
[TBL] [Abstract][Full Text] [Related]
11. Regulation of macrophage apoE secretion and sterol efflux by the LDL receptor.
Lucic D; Huang ZH; Gu de S; Altenburg MK; Maeda N; Mazzone T
J Lipid Res; 2007 Feb; 48(2):366-72. PubMed ID: 17079794
[TBL] [Abstract][Full Text] [Related]
12. Infectivity of hepatitis C virus is influenced by association with apolipoprotein E isoforms.
Hishiki T; Shimizu Y; Tobita R; Sugiyama K; Ogawa K; Funami K; Ohsaki Y; Fujimoto T; Takaku H; Wakita T; Baumert TF; Miyanari Y; Shimotohno K
J Virol; 2010 Nov; 84(22):12048-57. PubMed ID: 20826689
[TBL] [Abstract][Full Text] [Related]
13. Influence of the APOE genotype on hepatic stress response: Studies in APOE targeted replacement mice and human liver cells.
Dose J; Nebel A; Piegholdt S; Rimbach G; Huebbe P
Free Radic Biol Med; 2016 Jul; 96():264-72. PubMed ID: 27130033
[TBL] [Abstract][Full Text] [Related]
14. Plasma ApoE4 Levels Are Lower than ApoE2 and ApoE3 Levels, and Not Associated with Plasma Aβ40/42 Ratio as a Biomarker of Amyloid-β Amyloidosis in Alzheimer's Disease.
Nakamura T; Kawarabayashi T; Ueda T; Shimomura S; Hoshino M; Itoh K; Ihara K; Nakaji S; Takatama M; Ikeda Y; Shoji M
J Alzheimers Dis; 2023; 93(1):333-348. PubMed ID: 36970894
[TBL] [Abstract][Full Text] [Related]
15. Distinct pro-inflammatory properties of myeloid cell-derived apolipoprotein E2 and E4 in atherosclerosis promotion.
Igel E; Haller A; Wolfkiel PR; Orr-Asman M; Jaeschke A; Hui DY
J Biol Chem; 2021 Sep; 297(3):101106. PubMed ID: 34425108
[TBL] [Abstract][Full Text] [Related]
16. Apolipoprotein E in lipoprotein metabolism, health and cardiovascular disease.
Marais AD
Pathology; 2019 Feb; 51(2):165-176. PubMed ID: 30598326
[TBL] [Abstract][Full Text] [Related]
17. Apolipoprotein E4 in macrophages enhances atherogenesis in a low density lipoprotein receptor-dependent manner.
Altenburg M; Johnson L; Wilder J; Maeda N
J Biol Chem; 2007 Mar; 282(11):7817-24. PubMed ID: 17234631
[TBL] [Abstract][Full Text] [Related]
18. APOE2, E3, and E4 differentially modulate cellular homeostasis, cholesterol metabolism, and inflammatory response in isogenic iPSC-derived astrocytes.
de Leeuw SM; Kirschner AWT; Lindner K; Rust R; Budny V; Wolski WE; Gavin AC; Nitsch RM; Tackenberg C
Stem Cell Reports; 2022 Jan; 17(1):110-126. PubMed ID: 34919811
[TBL] [Abstract][Full Text] [Related]
19. Apolipoprotein E and oxidative stress in brain with relevance to Alzheimer's disease.
Butterfield DA; Mattson MP
Neurobiol Dis; 2020 May; 138():104795. PubMed ID: 32036033
[TBL] [Abstract][Full Text] [Related]
20. apoE isoform-specific disruption of amyloid beta peptide clearance from mouse brain.
Deane R; Sagare A; Hamm K; Parisi M; Lane S; Finn MB; Holtzman DM; Zlokovic BV
J Clin Invest; 2008 Dec; 118(12):4002-13. PubMed ID: 19033669
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
